MICHELLE NOWAK: Open Payments
NPI 1154674125 · NAPLES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$672 in 33 payments from 13 companies in 2025. Trend: 2023 $1,214 · 2024 $1,235 · 2025 $672
Food & beverage: $672
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $111 |
| Novo Nordisk Inc | 4 | $94 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| ABBVIE INC. | 3 | $63 |
| Radius Health, Inc. | 3 | $57 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| CVRx, Inc. | 1 | $23 |
| Insulet Corporation | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
Products named: LEQVIO, JARDIANCE, AIRSUPRA, VRAYLAR, Tymlos, GEMTESA, Barostim Neo System, Omnipod.
Industry payments across FL — which companies pay providers there.
